title: Electrical conductivity changes during irreversible electroporation treatment of brain cancer.
abstract: Irreversible electroporation (IRE) is a new minimally invasive technique to kill tumors and other undesirable tissue in a non-thermal manner. During an IRE treatment, a series of short and intense electric pulses are delivered to the region of interest to destabilize the cell membranes in the tissue and achieve spontaneous cell death. The alteration of the cellular membrane results in a dramatic increase in electrical conductivity during IRE as in other electroporation-based-therapies. In this study, we performed the planning and execution of an IRE brain cancer treatment using MRI reconstructions of the tumor and a multichannel array that served as a stereotactic fiducial and electrode guide. Using the tumor reconstructions within our numerical simulations, we developed equations relating the increase in tumor conductivity to calculated currents and volumes of tumor treated with IRE. We also correlated the experimental current measured during the procedure to an increase in tumor conductivity ranging between 3.42-3.67 times the baseline conductivity, confirming the physical phenomenon that has been detected in other tissues undergoing similar electroporation-based treatments.
authors.affiliation: Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Blacksburg, VA 24061, USA. pgarcia@vt.edu
authors.forename: Paulo A
authors.initials: PA
authors.lastname: Garcia
authors.forename: John H
authors.initials: JH
authors.lastname: Rossmeisl
authors.forename: Rafael V
authors.initials: RV
authors.lastname: Davalos
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D003198:Computer Simulation; D004553:Electric Conductivity; D018274:Electroporation / Q000379:methods*; D006801:Humans; D008954:Models, Biological; D013813:Therapy, Computer-Assisted / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents